I am a board-certified radiation oncologist with an expertise in treating primary genitourinary (prostate, bladder, kidney, and testicular) and head and neck (oral cavity, base of tongue, tonsil, ...

I am a neurosurgeon and scientist interested in the immunobiology and treatment of brain tumors, including tumors that have arisen from the brain (primary tumors) and tumors that have spread to the ...

Dr. Yueming Li studies disease mechanism of Cancer and Alzheimer’s, with the goal of developing novel therapeutics for clinical use.

Molecular Pharmacology Program Member David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.

Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.

En este video, se muestra qué esperar durante su cita en una unidad de infusión de MSK.

Learn how intermittent fasting is being explored by researchers for possible use in cancer treatment and prevention, including breast cancer.

Los medicamentos GLP-1 son medicamentos que se recetan para bajar de peso. Estos medicamentos también se usan para tratar la diabetes y las enfermedades del corazón. Si usted toma un medicamento GLP-1 ...

African American patients with colorectal cancer are less likely to have tumors that respond well to newer treatments such as targeted therapy and immunotherapy.

A new analysis found that alcohol intake was associated with a modest increased risk of melanoma. White wine was associated with the greatest risk, the authors noted. Two MSK experts dissected the ...

Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.

Meet Lisa DeAngelis, MSK's new Physician-in-Chief. She discusses her upbringing, her early career at MSK, and her top priorities as physician-in-chief.